Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 221 - 240 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Virtus Fertility Centre Singapore sets up a ReadyBaby Fertility Grant for those facing financial and family planning challenges

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

Diaphragm Pumps Market Projected to Reach $11.92 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

Inhaled Nitric Oxide Market to Reach $1.6 billion, Globally, by 2032 at 7.7% CAGR: Allied Market Research

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024
Related companies:  Xiyuan Anjian Pharmaceutical (Shanghai) Co., Ltd.

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024
Related companies:  Vanda Pharmaceuticals Inc.

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024

Read more ››
By: PR Newswire Association LLC. - 23 Apr 2024

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

Read more ››
By: GlobeNewswire - 22 Apr 2024

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

Read more ››
By: GlobeNewswire - 22 Apr 2024

ArriVent Appoints Kristine Peterson to its Board of Directors

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  ArriVent Biopharma, Inc.

OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  OrthoPediatrics Corp.

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  Abeona Therapeutics, Inc.

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  RxSight Inc.

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  Akoya Biosciences, Inc.

GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024

Read more ››
By: GlobeNewswire - 22 Apr 2024

Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  Tessera Therapeutics, Inc.

Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  Excision BioTherapeutics, Inc.

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  Fate Therapeutics, Inc.

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 22 Apr 2024
Related companies:  CRISPR Therapeutics AG
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑